Sign in Create account

Tejnaksh Healthcare Limited

Healthcare · Healthcare Services

BSE: 539428
₹12.21
▼ -0.89 (-6.79%)
Oct. 5, 2026 · BSE · bse_bhavcopy
Quality
61/100
Moderate
Valuation
89/100
Undervalued
Momentum
43/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹25 Cr
PE (TTM)
15.5
Industry median 48.2 (44 companies)
Price to Book
0.9
PEG (TTM)
-0.4
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-47.1
Free Cash Flow
₹1 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-17.65%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-40.60%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
-13.84%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-68.29%
as of Dec. 31, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
3.48%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
8.45
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
18.81
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
15.79%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
25.12%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
26.05%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
6.88%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
6.65%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
7.50%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (7.5%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-6.8%
Low 11.6600 · High 12.9800
1W return
-7.4%
Low 11.6600 · High 13.4000
1M return
-12.4%
Low 11.6600 · High 14.4500
52W return
-52.7%
Low 11.6600 · High 14.9500
Lifetime High ₹740.0000 (Feb. 14, 2017)
Lifetime Low ₹12.2100 (Oct. 5, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
12.8
10D
13.1
20D
13.5
50D
15.7
100D
19.2
200D
24.9

Delivery and volume

Day avg. delivery
63.7%
Week avg. delivery
83.3%
Month avg. delivery
89.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

12.28
Pivot
First resistance12.91
Second resistance13.60
Third resistance14.23
First support11.59
Second support10.96
Third support10.27
Day RSI28.6
Day MFI22.0
Day MACD-0.69
Day MACD signal-0.79

Beta

1M-0.38
3M0.24
1Y0.24
3Y0.67

Price change analysis

↓ -12.4%
Over 1 Month
LowHigh
11.6614.45
↓ -52.7%
Over 3 Months
LowHigh
11.6614.95
↓ -52.7%
Over 6 Months
LowHigh
11.6614.95
↓ -52.7%
Over 1 Year
LowHigh
11.6614.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 15.5 (own history: 19.4–32.7)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹2 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.1400

Ranks #54 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter73.83%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 73.83% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 31 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
26 Jun 2025 GUNTUPALLI SIVARAMAKRISHNA Bulk Sell 273,762 19.3600 BSE
4 Apr 2024 PIYUSH SECURITIES PVT LTD Bulk Sell 15,000 23.7500 BSE
4 Apr 2024 PIYUSH SECURITIES PVT LTD Bulk Buy 122,897 23.1900 BSE
4 Apr 2024 PIYUSH TRADES & CREDITS PRIVATE LIMITED Bulk Sell 125,000 23.1900 BSE
21 Mar 2024 PIYUSH TRADES & CREDITS PRIVATE LIMITED Bulk Buy 150,000 25.1000 BSE
21 Mar 2024 PIYUSH SECURITIES PVT LTD Bulk Sell 150,000 25.1000 BSE
29 Nov 2023 SIDHESHBHAI DEVABHAI RAVAL Bulk Sell 280 30.4100 BSE
29 Nov 2023 SIDHESHBHAI DEVABHAI RAVAL Bulk Buy 152,834 30.7300 BSE
6 Jan 2023 NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUND Bulk Buy 58,958 115.0200 BSE
27 Jan 2022 SMITA ANIL SHAH Bulk Sell 67,352 134.1500 BSE

All bulk and block deals →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Tejnaksh Healthcare Ltd - 539428 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct 2026 Company Update Tejnaksh Healthcare Ltd - 539428 - Announcement under Regulation 30 (LODR)-Change in Management
29 Sep 2026 AGM/EGM Tejnaksh Healthcare Ltd - 539428 - Shareholder Meeting / Postal Ballot-Outcome of AGM
4 Sep 2026 AGM/EGM Tejnaksh Healthcare Ltd - 539428 - Notice Of 19Th Annual General Meeting Of The Company To Be Held On 29Th September, 2026
4 Sep 2026 Others Tejnaksh Healthcare Ltd - 539428 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (18.8x)

Weaknesses

  • Low Return on Equity (7.5%)
  • Declining profit YoY (-68.3%)

Opportunities

  • Trading below book value (PB 0.90)
  • RSI in oversold territory (28.6) -- a technical rebound zone

Threats

  • Down 52.7% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Tejnaksh Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.